Clinical Trial Results TV
March 1, 2006: Nonsustained Ventricular Tachycardia Early After MI
This video is sponsored by the Duke Clinical Medical Series.

Topics include:
* Case Presentation
* Nonsustained Ventricular Tachycardia after AMI: What Does It Mean?
* Prevalence, Characteristics, and Prognostic Value of NSVT Early After MI
* Conclusions

The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.

The guest, Patrick Hranitzky, MD, has nothing to disclose regarding this CME activity.

Nonsustained Ventricular Tachycardia Early After MI

Please select your viewing options:

Windows Media: 56k 100k
RealPlayer: 56k 100k
Number Viewing:
Need a media player? Please choose one of the free downloads below:
Get Windows Media PlayerDownload RealPlayer

Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
10-19-2021 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted